Zacks Investment Research
29 Apr 2026, 23:42 UTC · 20w ago
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates
Verdict
Headline leans bullish. We score CNMD +0.60.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · CNMD
+0.60strongly bullish





